OTC · RBGLY
Consumer Defensive · Household & Personal Products
$13.99
Down-$0.07 (-0.50%)
Updated Aug 13, 2026, 6:54 PM
SID Score
5.3/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
RBGLY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning RBGLY.
RBGLY research
Company profile and research snapshot.
RECKITT BENCKISR GP S/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 16, 2026 | Jefferies | Hold | — |
| May 15, 2026 | RBC Capital Markets | Neutral | — |
| May 12, 2026 | Jefferies | Hold | — |
| Apr 28, 2026 | Deutsche | Hold | — |
| Apr 24, 2026 | Berenberg Bank | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 7, 2026
Reckitt Benckiser (RKT) rated Buy: 21% peer discount, strong FY2025 growth/margins, and litigation risk update. Reda here for a detailed analysis.
SeekingAlpha · Jul 31, 2026
SeekingAlpha · Jul 30, 2026
Reckitt Benckiser's operating profit, margin, and cash flow fell, but management remains confident about forward momentum. See why RBGLY stock is a Buy.
SeekingAlpha · Jul 29, 2026
Reckitt Benckiser delivered strong Q2 results, driving the stock above my £46/share price target and prompting a shift to 'HOLD'. Read the latest analysis on the RBGLY stock here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RBGLY.
